Grant: CIHR-ICRH Travel Awards - General pool
University of Calgary
$1,500.00
Serum Estradiol Levels and Cardiovascular Risk Associated with Gender-Affirming Hormone use in Transgender Women: A Systematic Review and Meta-Analysis
EF 2022-23
Résumé
Gender-affirming estrogen therapy (GAET) may increase cardiovascular (CV) risk in transgender women (male at birth with female gender identity). However, it is unclear if these risks are associated with GAET-resulting serum estradiol concentrations. Our objective was to determine the association between serum estradiol levels and CV-related mortality, adverse events and CV surrogate markers in transgender women.
Programme
CIHR-ICRH Travel Awards - General pool
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
480726
Name
Rytz Chantal
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases
Projecttitle
Serum Estradiol Levels and Cardiovascular Risk Associated with Gender-Affirming Hormone use in Transgender Women: A Systematic Review and Meta-Analysis
Programtype2
Undefined
Orgnameinp2
University of Calgary
Cihramount2
$1,500
Cihrequipment2
$0
Programname2
CIHR-ICRH Travel Awards - General pool
Keyworddelim
Cardiovascular Risk; Gender-Affirming Hormone; Systematic Review; Transgender Women
Abstract
Gender-affirming estrogen therapy (GAET) may increase cardiovascular (CV) risk in transgender women (male at birth with female gender identity). However, it is unclear if these risks are associated with GAET-resulting serum estradiol concentrations. Our objective was to determine the association between serum estradiol levels and CV-related mortality, adverse events and CV surrogate markers in transgender women.
Competitiondate
202301
Approvedterm2
1 yr 0 mth
Pinamesdelim
Rytz, Chantal
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $1,500~ $0~
